Maetzel Andreas 4
4 · KalVista Pharmaceuticals, Inc. · Filed Apr 29, 2021
Insider Transaction Report
Form 4
Maetzel Andreas
Senior Vice President Medical
Transactions
- Sale
Common Stock
2021-04-28$25.50/sh−10,620$270,810→ 25,507 total - Sale
Common Stock
2021-04-28$25.54/sh−10,000$255,387→ 507 total - Sale
Common Stock
2021-04-28$25.65/sh−507$13,005→ 0 total - Exercise/Conversion
Common Stock
2021-04-29$8.21/sh+14,662$120,375→ 27,518 total - Exercise/Conversion
Common Stock
2021-04-29$16.08/sh+13,368$214,957→ 40,886 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-04-27−11,017→ 48,983 totalExercise: $7.91Exp: 2027-03-07→ Common Stock (11,017 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2021-04-29−12,856→ 0 totalExercise: $7.91Exp: 2027-03-07→ Common Stock (12,856 underlying) - Exercise/Conversion
Common Stock
2021-04-27$7.91/sh+11,017$87,144→ 11,017 total - Sale
Common Stock
2021-04-27$25.79/sh−11,017$284,163→ 0 total - Exercise/Conversion
Common Stock
2021-04-28$7.91/sh+36,127$285,765→ 36,127 total - Sale
Common Stock
2021-04-28$25.25/sh−15,000$378,783→ 10,507 total - Exercise/Conversion
Common Stock
2021-04-29$7.91/sh+12,856$101,691→ 12,856 total - Sale
Common Stock
2021-04-29$25.04/sh−40,886$1,023,589→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-04-28−36,127→ 12,856 totalExercise: $7.91Exp: 2027-03-07→ Common Stock (36,127 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2021-04-29−14,662→ 6,038 totalExercise: $8.21Exp: 2028-06-03→ Common Stock (14,662 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2021-04-29−13,368→ 7,332 totalExercise: $16.08Exp: 2028-09-17→ Common Stock (13,368 underlying)
Footnotes (3)
- [F1]The option is fully vested.
- [F2]The option vests over a 4-year period: 1/48th on July 4, 2018, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
- [F3]The option vests over a 4-year period: 1/48th on October 18, 2018, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.